Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 44 results.
User Information
Export Records
  1. 1.   Distinct Biomarker Profiles and TCR Sequence Diversity Characterize the Response to PD-L1 Blockade in a Mouse Melanoma Model
  2. El Meskini,Rajaa; Atkinson,Devon; Kulaga, Alan; Abdelmaksoud,Abdalla; Gumprecht, Michelle; Pate, Nathan; Hayes, Susana; Oberst, Michael; Kaplan, Ian M.; Raber, Patrick; Van Dyke, Terry; Sharan,Shyam; Hollingsworth, Robert; Day, Chi-Ping; Merlino, Glenn; Ohler,Zoe
  3. Molecular cancer research : MCR. 2021, Aug 1; 19(8): 1422-1436.
  1. 2.   A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
  2. Nilsson, Monique B.; Sun, Huiying; Robichaux, Jacqulyne; Pfeifer, Matthias; McDermott, Ultan; Travers, Jon; Diao, Lixia; Xi, Yuanxin; Tong, Pan; Shen, Li; Hofstad, Mia; Kawakami, Masanori; Le, Xiuning; Liu, Xi; Fan, Youhong; Poteete, Alissa; Hu, Limei; Negrao, Marcelo; Tran, Hai; Dmitrovsky, Ethan; Peng, David; Gibbons, Don L.; Wang, Jing; Heymach, John
  3. SCIENCE TRANSLATIONAL MEDICINE. 2020, SEP 2; 12(559): pii: aaz4589.
  1. 3.   Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells
  2. Park, Jun Ho; Zhao, Ming; Oshiro, Hiromichi; Miyake, Kentaro; Higuchi, Takashi; Reynoso, Jose; Razmjooei, Sahar; Bouvet, Michael; Clary, Bryan; Zhang, Zhiying; Sugisawa, Norihiko; Yamamoto, Jun; Singh,Shree Ram; Hoffman, Robert M
  3. Anticancer research. 2019, Jul; 39(7): 3463-3467.
  1. 4.   Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring
  2. Kang, Zhigang; Stevanovic, Sanja; Hinrichs, Christian S.; Cao, Liang
  3. CLINICAL CANCER RESEARCH. 2017, NOV 15; 23(22): 6856-6862.
  1. 5.   A New View of Pathway-Driven Drug Resistance in Tumor Proliferation
  2. Nussinov, Ruth; Tsai, Chung-Jung; Jang, Hyunbum
  3. TRENDS IN PHARMACOLOGICAL SCIENCES. 2017, May; 38(5): 427-437.
  1. 6.   Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
  2. Logue, J. S.; Morrison, D. K.
  3. Genes & Development. 2012, Apr; 26(7): 641-650.
  1. 7.   Allosteric modulators can restore function in an amino acid neurotransmitter receptor by slightly altering intra-molecular communication pathways
  2. Nussinov, R.
  3. British Journal of Pharmacology. 2012, Apr; 165(7): 2110-2112.
  1. 8.   Allo-network drugs: harnessing allostery in cellular networks
  2. Nussinov, R.; Tsai, C. J.; Csermely, P.
  3. Trends in Pharmacological Sciences. 2011, Dec; 32(12): 686-693.
  1. 9.   Effect of North Bicyclo[3.1.0]hexane 2 '-Deoxy-pseudosugars on RNA Interference: A Novel Class of siRNA Modification
  2. Terrazas, M.; Ocampo, S. M.; Perales, J. C.; Marquez, V. E.; Eritja, R.
  3. Chembiochem. 2011, May; 12(7): 1056-1065.
  1. 10.   Effect of Host Genetics on Incidence of HIV Neuroretinal Disorder in Patients With AIDS
  2. Sezgin, E.; Hendrickson, S. L.; Jabs, D. A.; Van Natta, M. L.; Lewis, R. A.; Troyer, J. L.; O'Brien, S. J.; Grp, S. R.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2010, Aug; 54(4): 343-351.
  1. 11.   Method for analysis of nanoparticle hemolytic properties in vitro
  2. Dobrovoiskaia, M. A.; Clogston, J. D.; Neun, B. W.; Hall, J. B.; Patri, A. K.; McNeil, S. E.
  3. Nano Letters. 2008 8(8): 2180-2187.
  1. 12.   Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
  2. Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; McNeil, S. E.
  3. Molecular Pharmaceutics. 2008 5(4): 487-495.
  1. 13.   Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study
  2. Purdue, M. P.; Lan, Q.; Kricker, A.; Grulich, A. E.; Vajdic, C. M.; Turner, J.; Whitby, D.; Chanock, S.; Rothman, N.; Armstrong, B. K.
  3. Carcinogenesis. 2007, Mar; 28(3): 704-712.
  1. 14.   Recombineering: In vivo genetic engineering in E-coli, S-enterica, and beyond
  2. Sawitzke, J. A.; Thomason, L. C.; Costantino, N.; Bubunenko, M.; Datta, S.; Court, D. L.
  3. Advanced Bacterial Genetics: Use of Transposons and Phage for Genomic Engieering. 2007; 421 : 171-199.
  1. 15.   A new perspective in the Lewis acid catalyzed ring opening of epoxides. Theoretical study of some complexes of methanol, acetic acid, dimethyl ether, diethyl ether, and ethylene oxide with boron trifluoride
  2. Saenz, P.; Cachau, R. E.; Seoane, G.; Kieninger, M.; Ventura, O. N.
  3. Journal of Physical Chemistry A. 2006, Oct; 110(41): 11734-11751.
  1. 16.   Role of GADD34 in modulation of cisplatin cytotoxicity
  2. Fishel, M. L.; Rabik, C. A.; Bleibel, W. K.; Li, X. M.; Moschel, R. C.; Dolan, M. E.
  3. Biochemical Pharmacology. 2006, JAN 12; 71(3): 239-247.
  1. 17.   Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression
  2. Daar, E. S.; Lynn, H. S.; Donfield, S. M.; Lail, A.; O'Brien, S. J.; Huang, W.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2005, NOV 1; 192(9): 1597-1605.
  1. 18.   Correlates of human herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma
  2. Brown, E. E.; Whitby, D.; Vitale, F.; Fei, P. C.; Del Carpio, C.; Marshall, V.; Alberg, A. J.; Serraino, D.; Messina, A.; Gafa, L.; Goedert, J. J.
  3. International Journal of Epidemiology. 2005, OCT; 34(5): 1110-1117.
  1. 19.   High-resolution genome-wide mapping of transposon integration in mammals
  2. Yant, S. R.; Wu, X. L.; Huang, Y.; Garrison, B.; Burgess, S. M.; Kay, M. A.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2085-2094.
  1. 20.   A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma
  2. Brown, E. E.; Fallin, M. D.; Goedert, J. J.; Chen, R.; Whitby, D.; Foster, C. B.; Lauria, C.; Alberg, A. J.; Messina, A.; Montella, M.; Rezza, G.; Vitale, F.; Chanock, S. J.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, MAR; 14(3): 633-637.
  1. 21.   The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo
  2. Embury, S. H.; Matsui, N. M.; Ramanujam, S.; Mayadas, T. N.; Noguchi, C.; Diwan, H. A.; Mohandas, N.; Cheung, A. T. W.
  3. Blood. 2004, NOV 15; 104(10): 3378-3385.
  1. 22.   Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide - Possible recognition of the fusion complex
  2. Gerber, D.; Pritsker, M.; Gunther-Ausborn, S.; Johnson, B.; Blumenthal, R.; Shai, Y.
  3. Journal of Biological Chemistry. 2004, NOV 12; 279(46): 48224-48230.
  1. 23.   Efficacy of PLD-118, a novel inhibitor of Candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and Esophageal candidiasis caused by fluconazole-resistant C albicans
  2. Petraitis, V.; Petraitiene, R.; Kelaher, A. M.; Sarafandi, A. A.; Sein, T.; Mickiene, D.; Bacher, J.; Groll, A. H.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2004, OCT; 48(10): 3959-3967.
  1. 24.   Fraction of cases of acquired immunodeficiency syndrome prevented by the interactions of identified restriction gene variants
  2. Silverberg, M. J.; Smith, M. W.; Chmiel, J. S.; Detels, R.; Margolick, J. B.; Rinaldo, C. R.; O'Brien, S. J.; Munoz, A.
  3. American Journal of Epidemiology. 2004 159(3): 232-241.
  1. 25.   Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo
  2. Fitzgerald, W.; Sylwester, A. W.; Grivel, J. C.; Lifson, J. D.; Margolis, L. B.
  3. Journal of Virology. 2004 78(13): 7061-7068.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel